HIV/AIDS Clinical Trials

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00002231

Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons

Condition: Chronic Human Immunodeficiency Virus Type 1(HIV-1) Infection; Infection, Human Immunodeficiency Virus; Antiretroviral Therapy (ART)-naïve Adults

NCT ID: NCT01218113

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

Condition: HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections; Healthy

NCT ID: NCT00459693

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00004579

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00013572

Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing

Condition: HIV; HIV Infections

NCT ID: NCT00968188

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00027261

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples

Condition: HIV-1 Infections; HIV Infections

NCT ID: NCT00557245

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

Condition: Influenza; HIV; Vaccine; HIV Infections

NCT ID: NCT00996970

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00002204

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00001043

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00002441

A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00001136

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

Condition: HIV (Human Immunodeficiency Virus); Metabolic Syndrome; HIV Infections

NCT ID: NCT00857298

A Study of GENEVAX-HIV, a Possible Vaccine

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00002232

A Study to Test the Safety of Three Experimental HIV Vaccines

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00000946

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00121121

Phase 1 Safety Study of Two Experimental HIV Vaccines

Condition: AIDS Vaccines; HIV Infections; HIV-1

NCT ID: NCT00479999

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

Condition: Opioid-Related Disorders; Buprenorphine; HIV; Cognition; HIV Infections

NCT ID: NCT01108679

Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV

Condition: Hepatitis B; Hepatitis C; HIV; HIV Infections

NCT ID: NCT00926146

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Condition: HIV Infections; Fatigue; HIV Positive; AIDS; Healthy Volunteer; HV

NCT ID: NCT00106795

Impact of Nutrition Intervention on HIV/AIDS Infected Patients

Condition: Human Immunodeficiency Virus (HIV); Acquired Immune Deficiency Syndrome (AIDS)

NCT ID: NCT01171495

Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old

Condition: HIV (Human Immunodeficiency Virus)-Infected Adults

NCT ID: NCT00814762

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

Condition: HIV; HIV Infections

NCT ID: NCT00851383

Screening Protocol for HIV Vaccine Studies

Condition: HIV Seronegativity; HIV Infections

NCT ID: NCT00031304

Minocycline for HIV+ Cognitive Impairment in Uganda

Condition: HIV-associated Cognitive Impairment; HIV Infections

NCT ID: NCT00855062

Integration of Family Planning and HIV Services in Tanzania

Condition: HIV Infection; HIV Infections

NCT ID: NCT00941876

Statin Therapy to Improve Atherosclerosis in HIV Patients

Condition: Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections

NCT ID: NCT00965185

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00011037

The Shang Ring: A Novel Male Circumcision Device for HIV Prevention

Condition: Male Circumcision; HIV Prevention; HIV Infections

NCT ID: NCT00993811

Adherence to HIV Therapy in Heroin Addicts

Condition: HIV; Substance Abuse; HIV Infections

NCT ID: NCT01101815

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00006298

Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT01082692

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Condition: HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome

NCT ID: NCT00656851

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00076817

High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk

Condition: HIV-related Lymphoma; HIV Infections

NCT ID: NCT01045889

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Condition: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes

NCT ID: NCT00130286

A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00833781

Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00947947

Efficacy of Influenza Vaccine in HIV Infected Adults

Condition: HIV; Influenza; Vaccination; HIV Infections

NCT ID: NCT00757900

Exercise and Pioglitazone for HIV-Metabolic Syndromes

Condition: HIV Infections; Type 2 Diabetes; Obesity; HIV; AIDS; Cardiovascular Disease; Lipodystrophy

NCT ID: NCT00639457

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With HIV-1 Infection

Condition: H1N1 Influenza Virus; Human Immunodeficiency Virus Type 1 (HIV-1) Infection

NCT ID: NCT01032408

Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults

Condition: Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00187148

Treatment De-Intensification and Residual HIV-1 in Youth

Condition: HIV-1; HIV Infections

NCT ID: NCT00867854

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Condition: HIV Infections; Human Immunodeficiency Virus

NCT ID: NCT00299897

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT01541085

A Trial to Evaluate the Safety and Immunogenicity of tgAAC09, an HIV Vaccine Containing Clade C Gag-PR-ΔRT DNA in an Adeno-associated Virus (AAV) Capsid, Administered Twice, at Three Dosage Levels and Two Dosing Intervals

Condition: Human Immunodeficiency Virus Infections; HIV Infections

NCT ID: NCT00888446

A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.

Condition: HIV Seropositivity; Acquired Immunodeficiency Syndrome

NCT ID: NCT00381212

Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

Condition: HIV Seronegativity; HIV Preventive Vaccine

NCT ID: NCT01418235

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00083603

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

Condition: Acquired Immunodeficiency Syndrome; HIV-1 Infection

NCT ID: NCT00708110

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00000972

Safety and Immunogenicity Study of HIV-MAG Vaccine Co-administered With Human IL-12 pDNA Followed or Preceded by Ad35-GRIN/ENV HIV Vaccine in HIV-uninfected Volunteers

Condition: HIV Infections

NCT ID: NCT01496989

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Condition: Infection, Human Immunodeficiency Virus; HIV-1 Infection

NCT ID: NCT00398125

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00001072

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00115960

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00124007

DCVax Plus Poly ICLC in Healthy Volunteers

Condition: HIV-1 Infection; HIV Infection; Healthy Volunteers

NCT ID: NCT01127464

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000847

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules

Condition: HIV Infections

NCT ID: NCT00001076

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Condition: HIV Infections

NCT ID: NCT00001020

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Condition: HIV Infections

NCT ID: NCT00000846

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00001096

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Condition: HIV Infections

NCT ID: NCT00865566

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00001052

A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000871

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00054860

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

Condition: HIV-1; HIV Infections

NCT ID: NCT00849680

HIV Vaccine Study in HIV Positive Patients

Condition: HIV Infections

NCT ID: NCT01071031

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00301184

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

Condition: HIV Infections

NCT ID: NCT00000633

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)

Condition: HIV Infections

NCT ID: NCT00532974

A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

Condition: HIV Infections

NCT ID: NCT01371175

Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00141024

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00052182

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00125099

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

Condition: HIV Infections

NCT ID: NCT00413725

Suspended(En español)

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

Condition: HIV Infections

NCT ID: NCT00415649

Withdrawn(En español)

Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00125970

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

Condition: HIV Infections

NCT ID: NCT00498056

Withdrawn(En español)

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00384787

Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

Condition: HIV Infections

NCT ID: NCT00123968

Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00871078

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000904

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

Condition: HIV Infections

NCT ID: NCT00007423

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Condition: HIV Infections

NCT ID: NCT00001053

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Condition: HIV Infections

NCT ID: NCT00000795

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

Condition: HIV Infections

NCT ID: NCT00000798

A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons

Condition: HIV Infections

NCT ID: NCT00001060

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

Condition: HIV Infections

NCT ID: NCT00076037

A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

Condition: HIV Infections

NCT ID: NCT00076063

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00001055

Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00111605

Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa

Condition: HIV Infections

NCT ID: NCT00063778

A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000884

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

Condition: HIV Infections

NCT ID: NCT00002428

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000813

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00043511

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000899

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

Condition: HIV Infections

NCT ID: NCT00000746

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00117429

A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00000832

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Condition: HIV Infections

NCT ID: NCT00001026

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

Condition: HIV Infections

NCT ID: NCT00000845

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Condition: HIV Infections

NCT ID: NCT00107549

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Condition: HIV Infections

NCT ID: NCT00955006

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00016588

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00097838

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00000853

Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01095224

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

Condition: HIV Infections

NCT ID: NCT00001021

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

Condition: HIV Infections

NCT ID: NCT00001042

A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002206

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Condition: HIV Infections

NCT ID: NCT00001044

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

Condition: HIV Infections

NCT ID: NCT00000866

Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00071851

Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01103687

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00376090

Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052

Condition: HIV Infections

NCT ID: NCT00091416

Effects of Growth Hormone Releasing Hormone in HIV

Condition: HIV; HIV Lipodystrophy

NCT ID: NCT01263717

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT01546818

Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT01266616

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00472719

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Condition: To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT; To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

NCT ID: NCT01546376

A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT00001088

Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV

Condition: HIV Infections

NCT ID: NCT00057538

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)

Condition: HIV Infection; Bone Loss; Osteopenia; Osteoporosis

NCT ID: NCT01228318

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Condition: HIV Infections

NCT ID: NCT00856154

A Trial to Evaluate the Safety and Immunogenicity of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adult Volunteers

Condition: HIV Infections

NCT ID: NCT01215149

Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS

Condition: HIV Infection

NCT ID: NCT00280449

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00080106

Drug Interaction Study of PSI-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

Condition: HIV-1

NCT ID: NCT01177059

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Condition: HIV Infection

NCT ID: NCT00252148

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Condition: HIV; Burkitt's Lymphoma

NCT ID: NCT01516593

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00119873

Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01260727

A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers

Condition: HIV Infections

NCT ID: NCT01513135

Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00850616

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Condition: HIV Infections

NCT ID: NCT00000957

Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus

Condition: Acquired Immune Deficiency Syndrome; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; HIV Infections

NCT ID: NCT00499434

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

Condition: HIV Infections

NCT ID: NCT00001056

A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Condition: HIV Infections

NCT ID: NCT00001037

A Trial to Evaluate the Safety and Immunogenicity of TBC-M4, an Env, Gag, Tat-rev, and Nef-RT MVA HIV Vaccine and a Prime-Boost Regimen With ADVAX, an Env, Gag, Nef-tat and Pol DNA HIV Vaccine and TBC-M4

Condition: HIV Infections

NCT ID: NCT00902824

A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART

Condition: HIV-1 Infection

NCT ID: NCT01378156

A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)(COMPLETED)

Condition: HIV-1; HIV Infections

NCT ID: NCT00849732

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

Condition: HIV Infections; HIV-1

NCT ID: NCT00309205

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Condition: Latent Tuberculosis Infection; HIV Infections; Tuberculosis

NCT ID: NCT00692809

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

Condition: HIV Infections

NCT ID: NCT00000958

The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART

Condition: HIV-1 Infection

NCT ID: NCT01319383

Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

Condition: Cardiovascular Risk; HIV Infection

NCT ID: NCT00795717

Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

Condition: Placental Malaria Infection; HIV Infections; Stillbirth; Prematurity; Neonatal Deaths

NCT ID: NCT00270530

Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00695877

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

Condition: HIV Infections

NCT ID: NCT01376726

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

Condition: HIV Infections; Leukoencephalopathy, Progressive Multifocal

NCT ID: NCT00001048

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

Condition: HIV Infections

NCT ID: NCT00000858

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Condition: HIV Infections

NCT ID: NCT00062530

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00061243

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01578889

Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00073216

Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins

Condition: HIV Infections

NCT ID: NCT01054872

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002450

A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00005573

Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS

Condition: HIV Infections

NCT ID: NCT00505401

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00574600

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

Condition: HIV Infections

NCT ID: NCT01123915

A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00213044

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, With or Without a Candidate Vaccine

Condition: HIV Infections

NCT ID: NCT00238459

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)

Condition: HIV Infections

NCT ID: NCT00751595

Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00618605

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00122564

Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection

Condition: HIV

NCT ID: NCT01343225

Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00486408

Suspended(En español)

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

Condition: HIV Infections

NCT ID: NCT00820846

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

Condition: HIV Infections

NCT ID: NCT00801697

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00428337

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

Condition: HIV Infections

NCT ID: NCT00386633

A Study of HIV-infected Subjects Initiating Anti-HIV Drugs for the First Time

Condition: HIV Infections

NCT ID: NCT00595192

Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection

Condition: HIV Infections

NCT ID: NCT00390078

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Condition: HIV Infections; AIDS; Lopinavir; Treatment Failure

NCT ID: NCT01189695

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Condition: HIV Infections

NCT ID: NCT00056797

Study Evaluating Vaccine in Adults With HIV

Condition: HIV Infections

NCT ID: NCT00195312

HIV Vaccine Trial in Thai Adults

Condition: HIV Infection

NCT ID: NCT00223080

Resistance to HIV Infection

Condition: HIV Infections

NCT ID: NCT00069485

Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection

Condition: HIV Infections

NCT ID: NCT00183261

Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT

Condition: HIV Infection

NCT ID: NCT01024595

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Healthy

NCT ID: NCT00917904

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00917891

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002415

A Study of Anti-HIV Monoclonal Antibody KD-247

Condition: HIV Infections

NCT ID: NCT00917813

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00270218

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Condition: HIV Infections; TB

NCT ID: NCT00480558

Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63

Condition: HIV Infections

NCT ID: NCT00369031

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT01428596

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

Condition: Obesity; HIV Infections

NCT ID: NCT00267527

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

Condition: HIV Infections

NCT ID: NCT00321061

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00352911

Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine

Condition: HIV Infections

NCT ID: NCT00308620

A Trial to Evaluate the Safety and Immunogenicity of an Adjuvanted GSK Investigational HIV Vaccine Administered With Ad35-GRIN Investigational Vaccine

Condition: HIV Infections

NCT ID: NCT01264445

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Condition: HIV Infection

NCT ID: NCT01441193

Reactogenicity and Immunogenicity of Vaginal CNgp140

Condition: HIV Infections; Acquired Immune Deficiency Syndrome

NCT ID: NCT00637962

Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)

Condition: Acquired Immunodeficiency Syndrome; Disease Transmission, Vertical; HIV Infections

NCT ID: NCT00000590

PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection

Condition: HIV Infection

NCT ID: NCT00775424

Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults

Condition: HIV Infection

NCT ID: NCT00343941

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00100633

TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)

Condition: HIV Infections

NCT ID: NCT00910806

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00110578

Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects

Condition: HIV Infections

NCT ID: NCT00623259

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Condition: HIV Infections

NCT ID: NCT00002353

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01438606

EP46 NOVAA The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.

Condition: HIV Infection; Yellow Fever

NCT ID: NCT01426243

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Condition: HIV Infections

NCT ID: NCT00213005

Safety Study of MVA Smallpox Vaccine in HIV-Positive Subjects Who Are Vaccinia Naive

Condition: HIV Infections; Smallpox

NCT ID: NCT00282581

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected Vaccinia-Naive Adults

Condition: HIV Infections

NCT ID: NCT01571960

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

Condition: HIV Infections

NCT ID: NCT01549509

HIV-discordant Couple Intrauterine Insemination

Condition: Infertility; HIV Infections

NCT ID: NCT00975546

Available

The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002346

An Observational Study of People Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00103961

HIV Risk Reduction and Drug Abuse Treatment in Iran

Condition: Opiate Dependence; HIV Infections

NCT ID: NCT00398008

TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Condition: Lipodystrophy; HIV Infections

NCT ID: NCT00608023

Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT01121809

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00008463

Effects of HIV and Hepatitis C Virus on the Brain

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00494936

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

Condition: HIV Infections

NCT ID: NCT00027365

Pharmacotherapy for HIV+ Stimulant Dependent Individuals

Condition: HIV Infections; Cocaine Dependence

NCT ID: NCT00599573

The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00395720

Rapid HIV Testing for Emergency Department Patients

Condition: HIV Infections

NCT ID: NCT00676481

A Study to Prepare for Future HIV Vaccine Studies

Condition: HIV Infections

NCT ID: NCT00029744

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00058734

Male Circumcision and HIV Rates in Kenya

Condition: HIV Infections

NCT ID: NCT00059371

Candidate HIV Vaccine

Condition: HIV Infections

NCT ID: NCT00089531

CDC HIV Testing Guidelines: Unresolved Ethical Concerns

Condition: HIV Infections

NCT ID: NCT00564369

Cellulose Sulfate (CS) Gel and HIV in Nigeria

Condition: HIV Infections; Gonorrhea; Chlamydia Infections

NCT ID: NCT00120770

Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV

Condition: MSM; HIV Infections; Risky Behaviors

NCT ID: NCT01279005

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Condition: HIV Infections

NCT ID: NCT00448669

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

Condition: Opiate Dependence; HIV Infections

NCT ID: NCT00548275

Trial of SAVVY Vaginal Gel and HIV in Nigeria

Condition: HIV Infections

NCT ID: NCT00130078

Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

Condition: HIV Infections

NCT ID: NCT00672191

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00441298

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00122486

Utilization of HIV Clinical Services in Rural India

Condition: HIV Infections; Sexually Transmitted Infections

NCT ID: NCT00554567

Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00623753

Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling

Condition: Health Care Quality, Access, and Evaluation; Delivery of Health Care; Immune System Diseases; HIV Infections

NCT ID: NCT00119548

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Condition: HIV Infections

NCT ID: NCT00000956

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Condition: HIV Infections

NCT ID: NCT00000757

Development of a New HIV Vaccine

Condition: HIV Infections

NCT ID: NCT00051922

Effectiveness of the Diaphragm for HIV Prevention

Condition: HIV Infection

NCT ID: NCT00121459

PTSD and Risk Behavior in HIV Positive Female Adolescents

Condition: PTSD; Sexual Abuse; HIV Infections

NCT ID: NCT00271882

Extended Infant Post-Exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

Condition: HIV Infections

NCT ID: NCT00115648

Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497081

Motiv82Change: an HIV Prevention Study for Young Latino Men

Condition: HIV Infections

NCT ID: NCT00877695

Botswana Tenofovir Oral HIV Prophylaxis Trial

Condition: HIV Infection

NCT ID: NCT00111150

A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)

Condition: HIV Infections

NCT ID: NCT00000775

Efficacy Study of T Cell Vaccination in HIV Infection

Condition: HIV Infections

NCT ID: NCT00407836

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00545987

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Condition: HIV Infections; Herpes Genitalis

NCT ID: NCT00405821

A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

Condition: HIV Infections

NCT ID: NCT00679497

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Condition: HIV Infections

NCT ID: NCT01539226

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Condition: HIV Infections

NCT ID: NCT01092611

No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks

Condition: HIV Infections

NCT ID: NCT00690690

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

Metabolic and Psychological Changes Associated With Menopause Among Women With HIV

Condition: HIV Infections; Menopause

NCT ID: NCT01142817

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

HIV Screening in the Emergency Department Setting

Condition: HIV Infections

NCT ID: NCT00667186

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00594880

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Condition: HIV Infection

NCT ID: NCT00420355

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

Condition: HIV Infections

NCT ID: NCT00482027

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Condition: HIV Infections

NCT ID: NCT00625404

Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS

Condition: HIV Infections

NCT ID: NCT00546689

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)

Condition: HIV Infections

NCT ID: NCT00000968

Antigenic Competition in HIV Preventive Vaccines

Condition: HIV Infections

NCT ID: NCT01159990

A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Condition: HIV Infections

NCT ID: NCT00000745

TH9507 in Patients With HIV-Associated Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00123253

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Condition: Hepatitis B Virus; HIV Infections

NCT ID: NCT00476463

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00287677

Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00517569

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT01067417

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

Condition: Hypertriglyceridemia; HIV Infections

NCT ID: NCT00540111

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Condition: HIV Infections

NCT ID: NCT00000886

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00051454

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Condition: HIV Infections

NCT ID: NCT00005762

Lifestyle Modification and Metformin Use in the Treatment of HIV

Condition: HIV Infections; Metabolic Syndrome X

NCT ID: NCT00399360

The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho

Condition: AIDS/HIV PROBLEM; Sexually Transmitted Diseases

NCT ID: NCT01589965

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

Condition: HIV-infection

NCT ID: NCT01407237

Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)

Condition: HIV Infections

NCT ID: NCT00000630

HIV and Cardiovascular Risk

Condition: HIV Infections; Cardiovascular Disease

NCT ID: NCT00465426

AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

Condition: HIV Infections

NCT ID: NCT00121758

A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV

Condition: HIV Infection; Substance Abuse

NCT ID: NCT01362634

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00412477

Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring

Condition: HIV Infections

NCT ID: NCT01144013

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

Condition: HIV Infections

NCT ID: NCT00773708

Structured Treatment Interruption (STI) in Acute/Primary HIV

Condition: HIV Infections

NCT ID: NCT01293513

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002354

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

Condition: HIV Infections

NCT ID: NCT00002381

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

Condition: HIV Infections

NCT ID: NCT00000767

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

Condition: HIV Infection

NCT ID: NCT00320307

HIV Fat Redistribution and the Evaluation of Brown Fat

Condition: HIV Infections

NCT ID: NCT01098045

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Condition: HIV Infections

NCT ID: NCT00961883

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

Condition: HIV Infections

NCT ID: NCT00995241

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

Condition: HIV Infection

NCT ID: NCT01038401

Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults

Condition: HIV Infections

NCT ID: NCT00991354

Androgen Effects in HIV-infected Women

Condition: HIV Infection

NCT ID: NCT00095212

Subclinical Atherosclerosis in HIV-infected Patients

Condition: HIV Infections; Coronary Atherosclerosis

NCT ID: NCT00455793

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Condition: AIDS; HIV Infections

NCT ID: NCT00100698

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Condition: HIV; HIV-1; Human Immunodeficiency Virus

NCT ID: NCT00298350

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Condition: HIV Infections

NCT ID: NCT00069030

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00393120

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)

Condition: HIV Infections

NCT ID: NCT00000631

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Condition: Anus Neoplasms; HIV Infections

NCT ID: NCT00428285

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

Exercise for Patients With HIV Infections

Condition: HIV Infections; Lipodystrophy; Inflammation

NCT ID: NCT00910936

Engaging Care for HIV-Infected Adolescent Females.

Condition: HIV Infection

NCT ID: NCT00489034

Effects of Creatine and Resistance Exercise Training in People With HIV Infection

Condition: HIV Infections

NCT ID: NCT00484627

Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT01157442

Tuberculosis in HIV Infected Patients in Uganda

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00057421

Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

Condition: HIV Infections; Psoriasis

NCT ID: NCT00002143

Daclizumab to Treat HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00080431

Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

Condition: HIV Integrase, HIV Protease.

NCT ID: NCT01258374

Trial of SAVVY and HIV in Ghana

Condition: HIV Infections

NCT ID: NCT00129532

Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

Condition: HIV Infections; Memory

NCT ID: NCT00893815

Anal HPV Infection and Abnormal Cytology in HIV-infected Women

Condition: Cervical Cancer Screening; HIV Infections

NCT ID: NCT00933140

HIV Resistance and Treatment Strategies

Condition: HIV Infections

NCT ID: NCT00581802

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis

Condition: HIV Infection; Osteopenia; Osteoporosis

NCT ID: NCT01020045

Aspirin and Antiretroviral Therapy in HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00783614

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01529073

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00705926

Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China

Condition: HIV Infections; Gonorrhea; Chlamydia

NCT ID: NCT00644150

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00132210

Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS

Condition: HIV Infections

NCT ID: NCT00079560

Effectiveness of a Community-Level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-Risk Populations

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00710060

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Condition: HIV Infections; Herpes Genitalis; Venereal Diseases

NCT ID: NCT00122525

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Condition: HIV Infections; Cardiovascular Diseases; Hypertension

NCT ID: NCT00039975

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00848211

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

The Detection of Drug-Resistant HIV-1 in Taiwan

Condition: HIV Infections

NCT ID: NCT00690001

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

Condition: HIV Infection

NCT ID: NCT00367952

Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects

Condition: HIV Infections

NCT ID: NCT01144026

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

Condition: HIV Infections; Hypertension

NCT ID: NCT00564057

Safety of Acidform Lubricant in HIV-Uninfected Women

Condition: HIV Infections

NCT ID: NCT00850837

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

Condition: HIV Infections

NCT ID: NCT01423825

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

Condition: HIV Infections; Malaria

NCT ID: NCT00421473

Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance

Condition: HIV Infections; Insulin Resistance; Obesity

NCT ID: NCT00264251

Naïve HIV POC Monotherapy Trial

Condition: HIV Infections

NCT ID: NCT00617526

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Condition: HIV Infections; Streptococcus Pneumoniae

NCT ID: NCT00622843

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Condition: HIV Infection

NCT ID: NCT00131560

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00184951

Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00101374

A Study of DPC 817 in HIV-Infected Males

Condition: HIV Infections

NCT ID: NCT00040274

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults

Condition: HIV-1 Infections

NCT ID: NCT01151319

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00069498

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir

Condition: HIV Infections; HCV Infections

NCT ID: NCT01288417

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Condition: HIV Infections

NCT ID: NCT01040091

Study of Pharmacokinetics in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00433979

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01014481

Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya

Condition: Unintended Pregnancy; HIV Infections

NCT ID: NCT01001507

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00474435

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Safety Study of Elvucitabine in HIV-1 Subjects

Condition: HIV Infections

NCT ID: NCT00405249

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00397566

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Condition: HIV Infections; Dyslipidemia

NCT ID: NCT00447070

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients

Condition: HIV Infection

NCT ID: NCT01359800

The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00145561

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00102089

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)

Condition: HIV Infections

NCT ID: NCT01335191

DermaVir Patch (LC002) in HIV-1 Infected Patients Currently on HAART

Condition: HIV Infections

NCT ID: NCT00712530

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients

Condition: HIV Infection

NCT ID: NCT00190242

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00113412

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

Condition: HIV Infections

NCT ID: NCT01407497

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Condition: HIV Infections

NCT ID: NCT00121979

Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

Condition: HIV Infections

NCT ID: NCT00504452

Mild Neurocognitive Disorder in HIV Infection of the Brain

Condition: HIV-Associated Cognitive Motor Complex

NCT ID: NCT01547754

Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility

Condition: Candidiasis; HIV Infections

NCT ID: NCT00692783

DermaVir Patch (LC002) in HIV-1 Infected Treatment-naïve Patients

Condition: HIV Infections

NCT ID: NCT00711230

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002133

A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

Condition: HIV Infections

NCT ID: NCT00001121

The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients

Condition: HIV Infections; Diarrhea; Bacterial Vaginosis

NCT ID: NCT00536848

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Condition: HIV Infections

NCT ID: NCT00373048

Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

Condition: Lymphoma, Non-Hodgkin; HIV Infections

NCT ID: NCT00002221

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Condition: HIV Infections; Hepatitis C; HCV Infection

NCT ID: NCT00959699

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Condition: HIV Infection; Hemophilia A

NCT ID: NCT00797381

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00002360

A Study of CI-1012 in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002196

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

Condition: HIV Infection

NCT ID: NCT00091741

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Condition: HIV Lipodystrophy

NCT ID: NCT01511016

Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.

Condition: HIV Infections

NCT ID: NCT00002175

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

Condition: HIV Infections

NCT ID: NCT00063804

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

Condition: HIV Seropositivity

NCT ID: NCT01174914

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00316589

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Condition: HIV Infections; Lymphoma, Non-Hodgkin

NCT ID: NCT00432419

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Condition: HIV Infections

NCT ID: NCT00129194

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Condition: HIV Infection

NCT ID: NCT01289106

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00530972

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00594373

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00189904

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Condition: HIV Infection

NCT ID: NCT01433289

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

Condition: Neurocognitive Disturbance; HIV Infection

NCT ID: NCT01348282

A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults

Condition: HIV Infections

NCT ID: NCT00549523

Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women

Condition: HIV Infections

NCT ID: NCT00961272

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00038220

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection

NCT ID: NCT00002104

Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Condition: HIV Infections

NCT ID: NCT00665951

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Condition: HIV Infections

NCT ID: NCT00511368

Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01017536

Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

Condition: HIV Infection

NCT ID: NCT01275443

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Condition: AIDS; HIV Infections

NCT ID: NCT00095576

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00718536

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

Condition: HIV Infections

NCT ID: NCT00562510

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

Condition: HIV Infection

NCT ID: NCT01155037

"Prime-Boost" Vaccine Schedule for Prevention of HIV Infection

Condition: HIV Infections

NCT ID: NCT00109629

Prospective Longitudinal Pilot Study on the Effect of Intensification With Raltegravir +/- PI or NNRTI on HIV in the GALT

Condition: HIV Infections

NCT ID: NCT00884793

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00114699

A Pilot Study of LTB4 in HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00251537

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Withdrawn(En español)

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

Condition: Anxiety Disorders; HIV Infections

NCT ID: NCT00887679

Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

Condition: HIV Infections

NCT ID: NCT00709605

Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01151189

Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002098

Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002099

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection

Condition: HIV Infections

NCT ID: NCT01009762

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

Condition: HIV Infections

NCT ID: NCT00705679

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

Condition: HIV Infections; H1N1 Influenza

NCT ID: NCT01002040

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

Condition: HIV Positive

NCT ID: NCT01365065

Acupuncture and Herbal Treatment of Chronic HIV Sinusitis

Condition: HIV Infections; Sinusitis

NCT ID: NCT00002149

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

Condition: Acquired ImmunoDeficiency Syndrome (AIDS)

NCT ID: NCT00434512

Buprenorphine/Raltegravir Pharmacokinetic Interaction Study

Condition: HIV Infection; HIV Infections

NCT ID: NCT00858962

A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings

Condition: Male Circumcision; HIV Prevention; HIV Infections

NCT ID: NCT01150370

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00612755

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Condition: HIV Infections; Chronic Hepatitis C

NCT ID: NCT00196586

Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00350272

Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00006327

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002396

A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

Condition: HIV Infections

NCT ID: NCT00000852

An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.

Condition: HIV Infections

NCT ID: NCT00002194

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002209

Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Condition: HIV

NCT ID: NCT00634959

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

Condition: HIV Infections

NCT ID: NCT01549470

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Condition: HIV Infections; Liver Toxicity; Hepatitis Co-infection

NCT ID: NCT01273142

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00126880

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults

Condition: HIV Infections

NCT ID: NCT01479296

Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects

Condition: Human Immunodeficiency Virus Type 1 (HIV-1); HIV Infections

NCT ID: NCT00833482

HIV-1 Resistance at Screening for HIV Prevention Studies

Condition: HIV

NCT ID: NCT01204814

The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002363

A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes

Condition: HIV Infections

NCT ID: NCT00001012

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

Condition: Bacterial Infections; HIV Infections

NCT ID: NCT00002139

An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00000650

Safety and Immunogenicity of a Plasmid HIV Vaccine, ADVAX e/g + ADVAX p/N-t (ADVAX), in HIV Uninfected Adults.

Condition: HIV Infection

NCT ID: NCT00249106

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Condition: HIV Infection; Young Adult

NCT ID: NCT01269632

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

Condition: Immunologic Tests; HIV Infections

NCT ID: NCT00972725

The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002326

Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00082628

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

Condition: HIV Infections

NCT ID: NCT00002094

A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002341

Gene Transfer for HIV Using Autologous T Cells

Condition: HIV-1 Infection

NCT ID: NCT01153646

Exercise, Oxidative Stress and HIV

Condition: HIV Infections

NCT ID: NCT00950937

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

Condition: Chronic Hepatitis B; HIV Infections

NCT ID: NCT00221286

A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin

Condition: HIV Infections

NCT ID: NCT00001989

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-Nef vs. MVA-BN in HIV-1 Infected Patients

Condition: HIV Infection

NCT ID: NCT00189930

A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.

Condition: HIV Infections

NCT ID: NCT00002115

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002128

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

Condition: HIV Infections; Leukoencephalopathy, Progressive Multifocal

NCT ID: NCT00002270

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Condition: HIV Infections

NCT ID: NCT01524900

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000647

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000877

Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT

Condition: Insulin Resistance; Atherosclerosis; Cardiovascular Disease; HIV/AIDS; HIV Infections

NCT ID: NCT00958815

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 Mcg of Env 2-3 in MF59

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00000632

Preliminary Study of Safety and Efficacy of Policosanol

Condition: HIV-Related Dyslipidemia; HIV Infections

NCT ID: NCT00312923

Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT00855088

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Condition: HIV Infections; HIV Seronegativity; Lipodystrophy

NCT ID: NCT00017758

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00920426

TMC310911-TiDP21-C201 - A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-naive HIV-1-infected Patients

Condition: HIV-1 Infections

NCT ID: NCT00838162

A Study of MK-1439 in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)

Condition: HIV-1 Infection

NCT ID: NCT01466985

Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)

Condition: HIV-1 Infection

NCT ID: NCT01353898

Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial

Condition: HIV-1

NCT ID: NCT00337181

Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Condition: HIV Infections

NCT ID: NCT00643643

Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women

Condition: HIV-1 Infections

NCT ID: NCT00984152

MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)

Condition: HIV-1 Infection

NCT ID: NCT01152255

Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors

Condition: HIV-1 Infection

NCT ID: NCT01480713

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

Condition: HIV

NCT ID: NCT00270465

A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus

Condition: HIV Infections

NCT ID: NCT00000683

Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus

Condition: Dry Eye Syndromes; HIV Seropositivity

NCT ID: NCT00797030

Emotional Disclosure in HIV

Condition: HIV Infections

NCT ID: NCT00067704

Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women

Condition: HIV Infections

NCT ID: NCT01311752

Study of Enfuvirtide in HIV-Positive Subjects

Condition: HIV Infections; AIDS

NCT ID: NCT00086710

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Condition: Insulin Resistance; Cardiovascular Diseases; Heart Diseases; HIV Infections; Hypertriglyceridemia; Hyperlipidemia

NCT ID: NCT00246402

Randomized Controlled Trial of Stress Management Training in HIV

Condition: HIV Infections

NCT ID: NCT00436085

Cohort of HIV Associated Lymphomas

Condition: HIV Infection

NCT ID: NCT01164436

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00002399

A Medication Adherence Intervention for HIV Infected Veterans

Condition: HIV Infection

NCT ID: NCT00013065

Accelerated Aging, HIV Infection, Antiretroviral Therapies

Condition: HIV Infection; Aging Accelerated; Antiretroviral Therapies

NCT ID: NCT01038999

Selective Exposure in HIV Prevention

Condition: HIV Infections

NCT ID: NCT01152281

Women's Interagency HIV Study (WIHS)

Condition: HIV Infections

NCT ID: NCT00000797

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00111332

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Condition: HIV Infections

NCT ID: NCT00135434

Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study

Condition: HIV Infections

NCT ID: NCT00000787

Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy

Condition: Depression; HIV Infection

NCT ID: NCT00509340

Glutathione and Its Precursors in HIV-Infected Patients

Condition: HIV Infection

NCT ID: NCT00910442

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

Condition: HIV; AIDS

NCT ID: NCT01469520

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Condition: HIV Infections

NCT ID: NCT00659789

A Study of Azithromycin in HIV-Infected Patients

Condition: Bacterial Infections; HIV Infections

NCT ID: NCT00002344

Safety and Efficacy Trial of Subcutaneously Administered Serostim® in the Treatment of Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS)

Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS); HIV Infections

NCT ID: NCT00294164

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

Condition: HIV Infections

NCT ID: NCT00615563

Chloroquine for Reducing Immune Activation in HIV- Infected Individuals

Condition: HIV Infections

NCT ID: NCT00819390

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00393276

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

Condition: Cardiovascular Diseases; Heart Diseases; HIV Infections; Hyperlipidemia; Hypertriglyceridemia; Insulin Resistance; Atherosclerosis

NCT ID: NCT00246376

Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers

Condition: HIV Infections

NCT ID: NCT00771823

The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System

Condition: HIV Infections

NCT ID: NCT00002288

The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.

Condition: HIV Infections

NCT ID: NCT00000629

Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection

Condition: HIV Infection

NCT ID: NCT01065207

A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection

Condition: HIV Infections

NCT ID: NCT00001000

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Condition: HIV Infection

NCT ID: NCT00131677

Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations

Condition: HIV Infection; AIDS

NCT ID: NCT00347750

Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00361257

Terminated(En español)

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00617643

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

Condition: HIV Infections

NCT ID: NCT00435929

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

Condition: HIV Infections

NCT ID: NCT00355719

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00083330

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

Condition: Human Immunodeficiency Virus Infection; Hepatitis C

NCT ID: NCT01447680

A Study of MDL 28,574A in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002329

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002198

Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

Condition: HIV Infections; Insulin Resistance

NCT ID: NCT00025753

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

Condition: HIV Infections

NCT ID: NCT01047995

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00384904

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Condition: HIV Infections; H1N1 Influenza Virus

NCT ID: NCT00992017

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients

Condition: HIV Infections

NCT ID: NCT00661349

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00411957

Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection

Condition: HIV Infections

NCT ID: NCT00490412

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Condition: HIV Infections; Lipodystrophy; Hyperinsulinemia

NCT ID: NCT00015691

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine

Condition: HIV Infections

NCT ID: NCT00000835

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)

Condition: HIV Infections

NCT ID: NCT00350623

Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein

Condition: HIV Infections

NCT ID: NCT00529698

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00141284

A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

Condition: HIV Infections

NCT ID: NCT00000897

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00015652

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

Condition: HIV; HIV Infections

NCT ID: NCT01073761

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Condition: HIV Infections

NCT ID: NCT00000857

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/HCV Negative Volunteers

Condition: Hepatitis C; HIV

NCT ID: NCT01427504

Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda

Condition: HIV

NCT ID: NCT00342160

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-Infected Patients

Condition: Human Immunodeficiency Virus

NCT ID: NCT00333892

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

Condition: HIV Infections

NCT ID: NCT00002029

Case Management Alternatives for African American Women at High Risk for HIV

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00780260

Trial of an Anti-HIV-1 Gene Transfer Product

Condition: HIV-1

NCT ID: NCT00074997

An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)

Condition: HIV Infections

NCT ID: NCT00002255

PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers

Condition: HIV Infection; HIV Infections

NCT ID: NCT01108926

Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT00829114

ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

Condition: HIV Infections; Hepatitis B; Dyslipidemia

NCT ID: NCT00493506

The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection

Condition: HIV Infections

NCT ID: NCT00002298

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00812318

Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients

Condition: Human Immunodeficiency Virus

NCT ID: NCT01213186

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00945282

Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos

Condition: HIV; AIDS

NCT ID: NCT01452555

Increasing Condom Use in People at Risk for HIV Infection

Condition: HIV Infections

NCT ID: NCT00080093

Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant

Condition: HIV Infections

NCT ID: NCT00001019

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

Condition: HIV Infections

NCT ID: NCT00056745

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00490074

Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi

Condition: HIV

NCT ID: NCT01190605

Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand

Condition: HIV Infections

NCT ID: NCT00713531

Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

Condition: Human Immunodeficiency Virus

NCT ID: NCT00244803

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Condition: HIV Infections

NCT ID: NCT00000941

Influenza Vaccine in HIV

Condition: Influenza; HIV

NCT ID: NCT00764998

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-Based HAART in Advanced HIV Disease

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT00775606

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Condition: Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT01315301

HIV Risk Reduction in Subutex Injectors in Tbilisi

Condition: HIV

NCT ID: NCT01131273

Women-Focused HIV Prevention in the Western Cape

Condition: HIV; Substance Abuse; Violence

NCT ID: NCT00729391

Vaginal Innate Immunity in Normal and HIV-Infected Women

Condition: HIV; Pregnancy

NCT ID: NCT01318304

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

Condition: HIV

NCT ID: NCT01293123

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.

Condition: HIV; Pharmacokinetics

NCT ID: NCT00828815

Distant Healing for HIV/AIDS

Condition: HIV Infections; AIDS

NCT ID: NCT00079534

Zambia Exclusive Breastfeeding Study

Condition: HIV Infection

NCT ID: NCT00310726

The Role of Genital Warts in HIV Acquisition in Peru

Condition: Anogenital Warts; HIV

NCT ID: NCT01387412

Pre-Exposure Prophylaxis Using TMC278LA

Condition: HIV Infections

NCT ID: NCT01049932

Neighborhoods, Networks, Depression, and HIV Risk

Condition: HIV; Depression; Drug Use

NCT ID: NCT01380613

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Condition: HIV Infections; Malaria

NCT ID: NCT00266058

Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Condition: HIV; Malnutrition

NCT ID: NCT01548599

Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination

Condition: HIV; Rabies

NCT ID: NCT01286493

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Condition: HIV Infections

NCT ID: NCT00356616

Acceptability Study of Vaginal Films for HIV Prevention

Condition: HIV Infections; Anti-Infective Agents

NCT ID: NCT01231763

Study of Lifestyle Modification in HIV Lipodystrophy

Condition: HIV; Metabolic Diseases

NCT ID: NCT00111358

Eplerenone in HIV Associated Abdominal Fat Accumulation

Condition: HIV

NCT ID: NCT01405456

Botswana Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00385554

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Condition: HIV Infections; Contraception; Pharmacokinetics

NCT ID: NCT00482963

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

Condition: HIV Infections

NCT ID: NCT00040300

A Safety Study of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01071174

Early Immune Responses to Vaccination - A Substudy to HVTN 205

Condition: HIV Infections

NCT ID: NCT00908323

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337570

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337583

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00486330

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Condition: HIV

NCT ID: NCT01269515

Bangkok Tenofovir Study

Condition: HIV Infections

NCT ID: NCT00119106

Intrauterine Insemination In HIV-Discordant Couples

Condition: HIV-1; Fertility; Infertility

NCT ID: NCT01173276

Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

Condition: HIV Infections

NCT ID: NCT00540605

A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method

Condition: HIV Infections

NCT ID: NCT00469170

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Condition: HIV

NCT ID: NCT00299091

A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel

Condition: HIV Infections

NCT ID: NCT00304642

A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand

Condition: HIV; Herpes

NCT ID: NCT00362596

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00592124

A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women

Condition: HIV; AIDS

NCT ID: NCT00774683

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Condition: HIV; Hepatitis-B

NCT ID: NCT00476723

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096850

A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel

Condition: HIV Infections

NCT ID: NCT00303576

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

Condition: HIV Infections

NCT ID: NCT00469768

Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients

Condition: HIV

NCT ID: NCT01201239

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa

Condition: HIV Infections

NCT ID: NCT00304668

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Condition: HIV Seronegativity; AIDS Vaccines

NCT ID: NCT00047931

EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

Condition: HIV

NCT ID: NCT01509144

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Condition: HIV Infections

NCT ID: NCT00528489

The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda

Condition: Intimate Partner Violence; HIV

NCT ID: NCT00790959

Integrase Inhibitor (MK-0518) Viral Decay

Condition: HIV Infections

NCT ID: NCT00520897

Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine

Condition: HIV Infections

NCT ID: NCT01285141

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

Condition: HIV Infections; Insulin Resistance; Hyperlactatemia

NCT ID: NCT00471614

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

Condition: HIV Infections

NCT ID: NCT00613249

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Condition: HIV Infections; Cytopenias

NCT ID: NCT00002009

An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Condition: HIV Infections; Cytopenias

NCT ID: NCT00002008

Characteristics of Immune Cells in Gut Mucosa of HIV Negative and HIV Positive Thais

Condition: HIV-infection

NCT ID: NCT01397669

Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00255944

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

Condition: HIV Infections; Cognition Disorders

NCT ID: NCT00000392

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections

Condition: HIV Infections; Mycobacterium Infections; Tuberculosis

NCT ID: NCT00004276

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00273273

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Condition: HIV Infections; Cachexia

NCT ID: NCT00004400

American Ginseng to Improve HIV-Associated Fatigue

Condition: HIV/AIDS-associated Fatigue

NCT ID: NCT01500096

Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands

Condition: Behavioral Risk for HIV

NCT ID: NCT01592994

Botanical/Drug Interactions in HIV: Glucuronidation

Condition: HIV Seronegativity

NCT ID: NCT00065741

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

Condition: HIV Infection

NCT ID: NCT00659191

Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya

Condition: HIV Discordant Couples

NCT ID: NCT01468753

Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00441909

Depot Contraception With and Without Lopinavir/Ritonavir

Condition: HIV Infection

NCT ID: NCT01231451

Pharmacokinetics of Lamivudine at Two Different Doses

Condition: HIV Infections

NCT ID: NCT00985647

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Condition: Healthy Volunteers; HIV Infection

NCT ID: NCT00261001

Antiretroviral-Sparing Concept: Investigate the Effect of Therapeutic Immunization With DermaVir Patch

Condition: HIV Infections

NCT ID: NCT00918840

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

Condition: HIV Infections

NCT ID: NCT00355251

Cognitive Behavioral Stress Management for HIV+ Drug Abusers

Condition: HIV/AIDS; Drug Abuse; Alcohol Abuse

NCT ID: NCT00722644

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Condition: HIV Infections

NCT ID: NCT00729573

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Condition: HIV Infections

NCT ID: NCT00648817

Effects of IGF-I in HIV Metabolic Disease

Condition: HIV Lipodystrophy

NCT ID: NCT01329744

The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation Study

Condition: HIV Infections

NCT ID: NCT00703248

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART

Condition: HIV Infections

NCT ID: NCT00270205

Effects of Short-term Growth Hormone in HIV-infected Patients

Condition: HIV Lipodystrophy

NCT ID: NCT00795210

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women

Condition: HIV Infected

NCT ID: NCT01394133

Testosterone and Physical Function in HIV+ Men

Condition: HIV Associate Weight Loss

NCT ID: NCT00260143

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

Condition: HIV Associated Neurocognitive Disorder

NCT ID: NCT01354314

Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa

Condition: HIV Prevention

NCT ID: NCT01554423

Notification of Donors With Positive Microbiology Markers

Condition: Human Immunodeficiency Virus; Hepatitis B; Hepatitis C; Human T-lymphotropic Virus I & II; Creutzfeldt-Jakob Syndrome; HIV Infections

NCT ID: NCT01050881

Brief Intervention for Drug Misuse in the Emergency Department

Condition: Substance Abuse Detection; Acquired Immunodeficiency Syndrome; Hepatitis B; Hepatitis C; Brief Intervention; HIV Infections

NCT ID: NCT01124591

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

Condition: HIV-1

NCT ID: NCT01024842

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

Condition: HIV Negative; Adaptive Immunity; Innate Immunity

NCT ID: NCT01386489

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144157

Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-Dependent Adults

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00273988

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

Condition: HIV-1 Infection

NCT ID: NCT01549119

A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae; HIV Infection

NCT ID: NCT01215006

Intense Acute Infection Study

Condition: Acute HIV Infection

NCT ID: NCT01154673

Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT01433601

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT01045317

Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

Condition: Human Immunodeficiency Virus (HIV) Infection

NCT ID: NCT00821535

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002299

Effectiveness of HIV Risk Reduction Program Among African American Men

Condition: Sexually Transmitted Diseases; HIV

NCT ID: NCT00314028

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

Condition: HIV-1 Infections

NCT ID: NCT00799058

Residual Risk Assessment Of HIV Transmission

Condition: HIV Infection

NCT ID: NCT01413152

A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)

Condition: HIV Infections

NCT ID: NCT00002275

A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)

Condition: HIV Infections

NCT ID: NCT00001006

Integrated Treatment for Smoking Cessation & Anxiety in People With HIV Phase 1

Condition: Nicotine Dependence; Symptoms of Anxiety; HIV

NCT ID: NCT01393301

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

Condition: HIV Infections

NCT ID: NCT00110591

Thai Prophylactic Vaccine Study

Condition: HIV

NCT ID: NCT00333424

Not yet recruiting(En español)

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

Condition: Hepatitis C; HCV; HIV; AIDS

NCT ID: NCT00828789

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

Condition: HIV Infections; Sexually Transmitted Infections

NCT ID: NCT00670163

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

Condition: HIV Infections; Herpes Simplex

NCT ID: NCT01176409

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

Condition: HIV

NCT ID: NCT01346878

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

Condition: HIV

NCT ID: NCT00495677

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

Condition: HIV

NCT ID: NCT00765271

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

Condition: HIV

NCT ID: NCT01191203

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

Condition: HIV

NCT ID: NCT01320176

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

Condition: HIV Infections; Lipodystrophy; Insulin Resistance

NCT ID: NCT00006185

Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy

Condition: HIV

NCT ID: NCT01116817

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Condition: HIV; Dyslipidemia

NCT ID: NCT01458977

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

Condition: HIV; AIDS; Fungal Infection

NCT ID: NCT00740389

Pharmacokinetic Study Of EPZICOM Tablet

Condition: HIV Infection

NCT ID: NCT00337922

The Maraviroc Central Nervous System (CNS) Study

Condition: HIV Infections

NCT ID: NCT00982878

ATV/Ritonavir Nevirapine Interaction (USPAC)

Condition: HIV Infections

NCT ID: NCT00162149

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

Condition: HIV Infection

NCT ID: NCT01069809

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Condition: HIV Infections

NCT ID: NCT00621166

Garlic in Hyperlipidemia Caused by HAART

Condition: HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Hyperglycemia

NCT ID: NCT00029250

Raltegravir Insulin Sensitivity Study

Condition: HIV Infections

NCT ID: NCT00531999

A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring

Condition: HIV Infections

NCT ID: NCT01144676

A Dose Escalation Study of GS-7340-02 in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00036634

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00530920

A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

Condition: HIV Infections

NCT ID: NCT01242579

Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution

Condition: Substance-related Disorders; HIV Risk Behavior

NCT ID: NCT01560221

Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions

Condition: HIV-1

NCT ID: NCT01140139

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

Condition: HIV-1

NCT ID: NCT01084343

Extent of the Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in HIV Positive and HIV Negative Pregnant Women and Their Offsprings.

Condition: Streptococcal Infections; Gram-Positive Bacterial Infections; Bacterial Infections

NCT ID: NCT01412801

" Arthrospira Platensis" as Nutrition Supplementation for Female Adult Patients Infected by HIV in Yaoundé Cameroon

Condition: HIV

NCT ID: NCT01084382

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00985543

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Condition: TB; HIV

NCT ID: NCT01061593

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Condition: Chronic Hepatitis C; Co-Infection HIV-HCV

NCT ID: NCT00611819

Genetics and HIV-1 Protease Inhibitors

Condition: HIV

NCT ID: NCT01388543

Rifaximin as a Modulator of Microbial Translocation and Immune Activation

Condition: HIV-1 Infection

NCT ID: NCT01466595

Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00136643

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

Condition: HIV Infections

NCT ID: NCT00007332

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months

Condition: HIV Infections

NCT ID: NCT00000749

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Condition: HIV Infections

NCT ID: NCT00006207

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Condition: HIV Infections

NCT ID: NCT01363037

Assessing the Safety of Dapivirine Gel and Film Formulations

Condition: HIV Infections

NCT ID: NCT01548560

Trial of Collaborative Depression Care Management for HIV Patients

Condition: Depression; HIV

NCT ID: NCT01372605

Lipopeptide Immunisation With GTU-multiHIV Trial

Condition: HIV-1 Infection

NCT ID: NCT01492985

Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men

Condition: Human Immunodeficiency Virus Infection; Sexually Transmitted Diseases

NCT ID: NCT01490359

Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center

Condition: Sexually Transmitted Diseases; HIV Infections

NCT ID: NCT00267410

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Condition: HIV Infections

NCT ID: NCT00214812

An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina

Condition: HIV Infections

NCT ID: NCT00214747

Microbicides Acceptability Among Sexually Active Young Women

Condition: HIV Infections

NCT ID: NCT00490152

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497055

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)

Condition: HIV Infections

NCT ID: NCT00571961

CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

Condition: HIV Infections

NCT ID: NCT00870363

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

Condition: HIV Infections

NCT ID: NCT01052883

Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania

Condition: HIV Infections

NCT ID: NCT00631384

TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278

Condition: HIV Infections

NCT ID: NCT01031589

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

Condition: HIV Infections

NCT ID: NCT00002261

Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)

Condition: HIV Infections

NCT ID: NCT00690976

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

Condition: HIV Infections

NCT ID: NCT00700284

Effectiveness of Interactive Virtual Environment Games in Reducing Risky Sexual Behavior Among Men Who Have Sex With Men (The SOLVE-IT Study)

Condition: HIV Infections

NCT ID: NCT00653991

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Condition: HIV Infections

NCT ID: NCT00028132

Botswana Pediatric Respiratory Disease and Bloodstream Infection Study

Condition: HIV Infections; Respiratory Tract Diseases; Sepsis

NCT ID: NCT00197691

Effect of Antacids on the Pharmacokinetics of Raltegravir

Condition: HIV Infections

NCT ID: NCT00944307

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

Condition: HIV Infections

NCT ID: NCT00971230

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa

Condition: HIV Infection

NCT ID: NCT00931346

Study to Reduce Intravenous Exposures (STRIVE)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00391482

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00332306

A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae; Infection, Human Immunodeficiency Virus

NCT ID: NCT01209117

Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

Condition: Cholera; Vibrio Infections; Diarrhea

NCT ID: NCT00741637

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

Condition: HIV Infections

NCT ID: NCT00357604

Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00318409

GSK1349572 Relative Bioavailability Study

Condition: HIV Infections

NCT ID: NCT01098513

Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

Condition: HIV Infections

NCT ID: NCT00344123

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

Condition: HIV Infections

NCT ID: NCT00362726

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

Condition: HIV Infection

NCT ID: NCT01475227

Genetic Predictors of Variability in the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00630734

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir

Condition: HIV Infections

NCT ID: NCT00365339

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00408642

Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00132444

Healthy Activities for Prize Incentives

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00717444

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

Condition: HIV Infections

NCT ID: NCT00994344

Examination of B Cell Responses in Human Blood

Condition: HIV Infections

NCT ID: NCT00806845

A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.

Condition: HIV Infection

NCT ID: NCT00386347

TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT01001247

Bioequivalency Study of Zidovudine Under Fasting Conditions

Condition: HIV Infections

NCT ID: NCT00602550

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Condition: HIV Infections

NCT ID: NCT00413153

TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

Condition: HIV Infections

NCT ID: NCT01288755

Bioequivalency Study of Zidovudine Under Fed Conditions

Condition: HIV Infections

NCT ID: NCT00601562

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-Child Transmission (PMTCT)

Condition: HIV Infections

NCT ID: NCT00346567

Observational Study of Blood Treated With Cytolin

Condition: HIV Infections

NCT ID: NCT01048372

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

Condition: Healthy; HIV Infections

NCT ID: NCT01056874

Drug Interaction - Oral Contraceptive

Condition: HIV Infections

NCT ID: NCT00399685

Pharmacokinetics Study on Nevirapine Resistance in Tanzania

Condition: HIV Infections

NCT ID: NCT00294892

High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma

Condition: AIDS-Related Lymphoma; HIV Infections

NCT ID: NCT00858793

Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa

Condition: Spontaneous Abortion; Malaria; Pregnancy Outcome; Stillbirth; HIV Infections

NCT ID: NCT00878098

Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir

Condition: HIV

NCT ID: NCT01597180

A Key Link for Transmission Prevention

Condition: HIV

NCT ID: NCT01450189

DDI HV (ATV - Merck)

Condition: HIV Infections

NCT ID: NCT00518297

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Condition: HIV Infections

NCT ID: NCT00977301

The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)

Condition: HIV Infections; Depression; Mild Cognitive Impairment

NCT ID: NCT01246804

Education Program to Promote Female Condom Use

Condition: HIV Infections

NCT ID: NCT00062634

A Tailored Interactive Website for Promoting Condom Use Among Young Adults

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00183638

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00661960

Safety Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00446979

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

Condition: HIV Infections

NCT ID: NCT00332995

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

Condition: HIV Infections

NCT ID: NCT00561496

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Condition: HIV Infections

NCT ID: NCT00379405

Genetic Determinants of the Metabolism of Non-Nucleoside Reverse Transcriptase Inhibitors

Condition: HIV Infections

NCT ID: NCT00730223

A Randomized Controlled Trial of the Bruthas Project

Condition: HIV Infection

NCT ID: NCT01270230

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Condition: HIV Infections

NCT ID: NCT00414635

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

Condition: HIV Infections

NCT ID: NCT00312039

Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)

Condition: HIV Infection; Substance Abuse

NCT ID: NCT01327898

An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment

Condition: HIV Infections

NCT ID: NCT00675844

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

Condition: HIV Infections

NCT ID: NCT00334659

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT01068925

Botswana Diarrheal Diseases Study

Condition: HIV Infections

NCT ID: NCT00197652

Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand

Condition: HIV Infection

NCT ID: NCT00197639

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Condition: HIV; AIDS; Tuberculosis

NCT ID: NCT00737724

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females

Condition: HPV-16/18 Infections; Cervical Neoplasia

NCT ID: NCT00586339

Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses

Condition: Male Circumcision; HIV Prevention

NCT ID: NCT01434628

Phase I/II Study of Curdlan Sulfate

Condition: HIV Infections

NCT ID: NCT00002100

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002301

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Condition: HIV Infections

NCT ID: NCT00001112

A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients

Condition: HIV Infections

NCT ID: NCT00002013

Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002121

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Condition: Bacterial Infections; Mycoses; HIV Infections

NCT ID: NCT00000826

Evaluation of the Interaction Between Acetaminophen and Zidovudine

Condition: HIV Infections

NCT ID: NCT00000731

Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)

Condition: HIV Infections

NCT ID: NCT00002031

Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine

Condition: HIV Infections

NCT ID: NCT00000732

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002432

The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS

Condition: HIV Infections

NCT ID: NCT00002433

Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine

Condition: HIV Infections

NCT ID: NCT00000734

The Safety and Effectiveness of 524W91

Condition: HIV Infections

NCT ID: NCT00002335

An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002039

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

Condition: Lymphatic Disease; HIV Infections

NCT ID: NCT00002061

A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002163

An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients

Condition: HIV Infections

NCT ID: NCT00002266

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Condition: HIV Infection

NCT ID: NCT00352066

Cognitive Stimulation Program in AIDS

Condition: HIV Infections

NCT ID: NCT00619567

A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex

Condition: HIV Infections; Cytopenias

NCT ID: NCT00002281

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Condition: HIV Infections

NCT ID: NCT00000986

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Condition: HIV Infections; Malaria

NCT ID: NCT00697892

The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease

Condition: Lymphatic Disease; HIV Infections

NCT ID: NCT00002296

A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP

Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

NCT ID: NCT00000998

HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease

Condition: AIDS Vaccines

NCT ID: NCT01141205

Men Who Have Sex With Men (MSM) Neurocog 1&2 Study

Condition: HIV Related Neurocognitive Impairment

NCT ID: NCT01508559

Fuzeon Viral Decay Pilot Study

Condition: HIV-1

NCT ID: NCT00334022

Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

Condition: HIV

NCT ID: NCT01386970

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

Condition: Prevention of Infection With HIV-1

NCT ID: NCT01292174

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Condition: Tuberculosis (TB)

NCT ID: NCT00707967

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

Condition: HIV Infections

NCT ID: NCT01374802

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

Condition: HIV Infections; Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Depression; Substance Abuse

NCT ID: NCT00316303

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

Condition: HIV Infections

NCT ID: NCT00908414

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)

Condition: HIV Infections

NCT ID: NCT00665717

Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

Condition: Candidiasis, Oral; HIV Infections

NCT ID: NCT00005920

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00005921

Atazanavir Twice Daily

Condition: HIV Infections; Protease Inhibitor

NCT ID: NCT00357721

TMC 125 Blood Levels Study

Condition: HIV Infections

NCT ID: NCT00531323

A Study of BufferGel in Women

Condition: HIV Infections

NCT ID: NCT00000927

Bioequivalence Study of Atazanavir 300 mg Capsule

Condition: HIV Infections

NCT ID: NCT00393328

A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers

Condition: HIV Infections

NCT ID: NCT01268839

Drug Interaction Study With Proton Pump Inhibitor

Condition: HIV Infections

NCT ID: NCT00357240

Pharmacokinetic Study on Raltegravir and Lamotrigine

Condition: HIV Infection

NCT ID: NCT00618241

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

Condition: HIV Infections

NCT ID: NCT00622141

A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea

Condition: HIV Infections

NCT ID: NCT00002444

The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

Condition: HIV Infections

NCT ID: NCT00982553

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Condition: HIV Infections

NCT ID: NCT00491556

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infection

NCT ID: NCT01232660

Impact of Raltegravir on the Viral Reservoirs

Condition: HIV Infection

NCT ID: NCT01249560

Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight

Condition: HIV Infection

NCT ID: NCT01335360

Metabolic Effects of Enfuvirtide in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00657761

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Condition: HIV Infection; Fungal Infection

NCT ID: NCT00817765

Neurocognitive Assessment in Youth Initiating HAART

Condition: HIV Infections

NCT ID: NCT00683579

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00050180

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

Condition: HIV Infections; HSV-2 Genital Herpes

NCT ID: NCT00740584

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

Condition: HIV Infections; Protease Inhibitor

NCT ID: NCT00357188

Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00000690

Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.

Condition: HIV Infections; Healthy

NCT ID: NCT01276990

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

Condition: HIV Infections

NCT ID: NCT01101893

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen

Condition: HIV Infection

NCT ID: NCT01190293

Drug Drug Interaction of BI 201335 and Tenofovir

Condition: HIV Infections

NCT ID: NCT01340196

Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467518

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Condition: Tuberculosis

NCT ID: NCT01262976

Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis

Condition: Oral Candidiasis

NCT ID: NCT00659971

Increasing Viral Testing in the Emergency Department

Condition: Drug Use; HIV; Hepatitis C

NCT ID: NCT01419899

Drug-Drug Interaction (DDI) H2 Antagonists

Condition: HIV

NCT ID: NCT01232127

Trial to Study Ability to Reduce Viral Load and to Assess Safety and Toleration of UK 453,061

Condition: HIV

NCT ID: NCT00348673

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

Condition: Atherosclerosis

NCT ID: NCT01519141

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

Condition: HIV

NCT ID: NCT01348763

Sitagliptin and HIV

Condition: Inflammation; Macrophage Infiltration; Cardiovascular Disease

NCT ID: NCT01552694

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Condition: Drug Interactions; Human Immunodeficiency Virus

NCT ID: NCT01227590

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition: Hepatitis C

NCT ID: NCT01467479

A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01031472

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Condition: Human Immunodeficiency Virus

NCT ID: NCT01348516

Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

Condition: Human Immunodeficiency Virus

NCT ID: NCT01027182

Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A

Condition: HIV-1 Infection

NCT ID: NCT00380159

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01597648

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01332565

GSK706769/KALETRA Drug-drug Interaction Study

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00723775

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

Condition: Tuberculosis; HIV

NCT ID: NCT00828529

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

Condition: HIV; Asthma

NCT ID: NCT00936793

Pre-Exposure Prophylaxis in YMSM

Condition: HIV

NCT ID: NCT01033942

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01593046

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Condition: Human Immunodeficiency Virus

NCT ID: NCT01403792

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Condition: Human Immunodeficiency Virus I Infection

NCT ID: NCT01283100

Suspended

Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01382238

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467531

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Condition: HIV; Fenofibrate; Protease Inhibitors; Hypertriglyceridemia; Glucuronosyltransferase

NCT ID: NCT01148004

Risk Reduction Intervention for Vulnerable Young Adult Males

Condition: Sex; Substance Use; HIV

NCT ID: NCT01118416

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

Condition: HIV

NCT ID: NCT00767117

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Condition: Hepatitis C; HIV

NCT ID: NCT01336829

Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction

Condition: HIV

NCT ID: NCT01410058

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

Condition: HIV; AIDS; Hepatic Impairment

NCT ID: NCT00736905

Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting

Condition: HIV

NCT ID: NCT01284088

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users

Condition: HIV; Drug Use Disorders

NCT ID: NCT01413529

TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.

Condition: HIV-1

NCT ID: NCT00741741

Drug Interaction Study Between Digoxin and TMC278

Condition: HIV-1

NCT ID: NCT01519128

Directly Observed Antiretroviral Therapy Among Active Drug Users

Condition: HIV/AIDS; Substance Abuse

NCT ID: NCT00367172

S.T.A.R.S.: Sistas Talking About Real Solutions

Condition: HIV Prevention

NCT ID: NCT01028157

Microbicide Safety and Acceptability in Young Men

Condition: High Risk MSM; HIV Negative; 18-30 Years of Age

NCT ID: NCT01283360

PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir

Condition: HIV-1

NCT ID: NCT00838760

TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation

Condition: Pharmacokinetics; Bioavailability; HIV-1

NCT ID: NCT00812292

Observational Study of the Preventive Trial With HIV-1 Tat Protein

Condition: Healthy Subjects

NCT ID: NCT01024764

Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs

Condition: Human Immunodeficiency Virus Positive or Negative

NCT ID: NCT00245531

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT01273103

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Condition: Human Immunodeficiency Virus

NCT ID: NCT00333736

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Condition: Human Immunodeficiency Virus; Facial Lipoatrophy

NCT ID: NCT00333684

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01563328

GSK1349572 Drug Interaction Study With Protease Inhibitors

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00774735

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01498861

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01138072

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01195974

GSK706769 Repeat Dose Study

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00711386

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00920088

DDI Study of Etravirine and GSK1265744

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00920296

Drug Interaction Study Between Dolutegravir and Prednisone

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01425099

Early Versus Delayed Pneumococcal Vaccination in HIV

Condition: Pneumococcal Infections

NCT ID: NCT00137605

GSK1349572 Drug Interaction Study With Efavirenz

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae; Healthy

NCT ID: NCT01098526

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01209065

A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

Condition: Healthy Volunteer; Infections, Human Immunodeficiency Virus and Tuberculosis

NCT ID: NCT01214993

Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

Condition: HIV

NCT ID: NCT01276600

Comparative Tolerability of Protease Inhibitors

Condition: HIV

NCT ID: NCT01450618

Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

Condition: HIV

NCT ID: NCT00235222

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.

Condition: HIV; AIDS; Oral Contraceptive

NCT ID: NCT00739622

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Condition: Hepatitis C; Telaprevir; HIV

NCT ID: NCT00775125

Raltegravir and Ezetimibe PK Study

Condition: HIV

NCT ID: NCT00772551

Not yet recruiting(En español)

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

Condition: HIV

NCT ID: NCT00260767

Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers

Condition: Tuberculosis; HIV

NCT ID: NCT00992069

TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.

Condition: HIV

NCT ID: NCT00744770

Taste Assessment Study of Two Atazanavir Powder Formulations in Healthy Subjects

Condition: HIV

NCT ID: NCT01404572

Cameroon Mobile Phone SMS Trial

Condition: Adherence; HIV

NCT ID: NCT01247181

Levels of Raltegravir in the Female Genital Tissue

Condition: HIV

NCT ID: NCT01327482

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

Condition: HIV; AIDS

NCT ID: NCT00744887

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Condition: Opiate Dependence

NCT ID: NCT00383045

HIV/STI Prevention for Drug-Involved Couples

Condition: Sexually Transmitted Diseases

NCT ID: NCT01285349

Medicinal Cannabis for Painful HIV Neuropathy

Condition: Neuropathic Pain

NCT ID: NCT00255580

Project N-Liten- HIV Prevention for African American Women

Condition: Sexually Transmitted Diseases

NCT ID: NCT01553682

An Innovative HIV Prevention Intervention Using Social Networking Technology

Condition: Sexual Risk; Substance Use

NCT ID: NCT01381653

Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior

Condition: Cocaine Dependence

NCT ID: NCT00368290

Behavioral Depression Treatment for African American HIV-infected Substance Users

Condition: Major Depressive Disorder; Substance Use

NCT ID: NCT01351454

Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-Infected Patients Receiving Single-Dose Prednisone

Condition: Healthy

NCT ID: NCT00072644

Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)

Condition: Unsafe Sex; Risk Reduction

NCT ID: NCT01376895

Vaccine Treatment for HIV-Infection

Condition: Healthy

NCT ID: NCT00108654

Drug Interaction Study

Condition: Antivirals/HIV

NCT ID: NCT00646776

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

Condition: Healthy; Pharmacokinetics

NCT ID: NCT00176033

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Condition: Alcohol Abuse

NCT ID: NCT00371969

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

Condition: HIV Prevention

NCT ID: NCT01369303

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

Condition: HIV Prevention

NCT ID: NCT01421368

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Condition: Leukemia; Lymphoma

NCT ID: NCT00003435

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

Condition: HIV-I

NCT ID: NCT00854204

Effects of Manualized Treatment in a Seamless System

Condition: Substance Abuse; Offenders; Criminal Thinking; HIV Risk Behaviors

NCT ID: NCT01372033

Employment-Based Reinforcement to Motivate Naltrexone Ingestion and Drug Abstinence in the Treatment of Drug Addiction. - 1

Condition: Behavior Therapy; Cocaine; Cocaine (IV); Cocaine Abuse; Cocaine Dependence; Contingency Management; HIV Risk Behaviors; Heroin; Heroin Dependence; Naltrexone; Opioid Dependence; Substance Abuse, Intravenous; Sexual Risk Behaviors

NCT ID: NCT00149669

Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue

Condition: HIV/AIDS

NCT ID: NCT00775294

HIV Testing and Brief Alcohol Intervention for Young Drinkers in the Emergency Department

Condition: Alcohol Consumption; Sexual Risk Behaviors

NCT ID: NCT01573065

Single Dose Truvada in HIV-negative Men and Women

Condition: Pharmacokinetic Study in Healthy Volunteers

NCT ID: NCT01326221

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Condition: Influenza

NCT ID: NCT00992433

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Condition: Endothelial Dysfunction

NCT ID: NCT00720590

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Condition: NVP Plasma Level; NVP Related Mutation; 3TC Related Mutation

NCT ID: NCT00872872

AIDS Wasting in Women: Anabolic Effects of Testosterone

Condition: AIDS Wasting Syndrome

NCT ID: NCT00006158

Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy

Condition: Neuropathy; AIDS

NCT ID: NCT01135251

HIV Counseling Intervention for Methadone-Maintained Patients - 2

Condition: Opioid-Related Disorders

NCT ID: NCT00061100

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

Condition: Tuberculosis

NCT ID: NCT00731471

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

Condition: Diabetes; Insulin Resistance

NCT ID: NCT01093651

Relapse Prevention to Reduce HIV Among Women Prisoners

Condition: Opioid Relapse

NCT ID: NCT00763958

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Condition: Opiate Dependence

NCT ID: NCT01389167

Behavioral Drug and HIV Risk Reduction Counseling With MMT in China

Condition: Opiate Dependence

NCT ID: NCT01389180

Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1

Condition: Adherence; Behavior Therapy; Depression; Heroin Dependence; Methadone; Motivational Interviewing; Substance-Related Disorders

NCT ID: NCT00218634

Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk

Condition: Alcohol Consumption; Unsafe Sex

NCT ID: NCT01351389

Influenza Vaccine Trial in HIV Uninfected Pregnant Women

Condition: Influenza

NCT ID: NCT01306669

Pharmacokinetic and GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women

Condition: Genital Herpes

NCT ID: NCT00808405

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Condition: Influenza

NCT ID: NCT01538940

Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women

Condition: Influenza

NCT ID: NCT01527825

Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity

Condition: Influenza

NCT ID: NCT01306682

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Condition: Bacterial Vaginosis; Candidiasis; Trichomoniasis

NCT ID: NCT01230814

Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

Condition: Acceptability of Different Contraceptive Injection Types

NCT ID: NCT01578447

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Condition: TB Multi-drug Resistant

NCT ID: NCT00396084

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Condition: Hepatitis C

NCT ID: NCT00857311

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Condition: AIDS

NCT ID: NCT01344148

Antidepressant Treatment of AIDS Related Depression.

Condition: Depression

NCT ID: NCT00000390

A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA

Condition: Healthy Volunteer

NCT ID: NCT00520273

Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients

Condition: Insulin Resistance

NCT ID: NCT00483392

Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1

Condition: Behavior Therapy; Methamphetamine

NCT ID: NCT00249678

Influence of Nevirapine on HCV Viral Load

Condition: HCV Infection.; HCV Viral Load.

NCT ID: NCT01277627

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00569985

Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines

Condition: Healthy Volunteers

NCT ID: NCT01461447

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Condition: Kaposi´s Sarcoma

NCT ID: NCT01296815

Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi

Condition: Bacterial Vaginosis; Trichomonas Vaginitis; Urogenital Diseases

NCT ID: NCT00140764

Anxiety Sensitivity Treatment for Heroin Users

Condition: Anxiety

NCT ID: NCT01196312

Antiretroviral Drug Levels During and After Pregnancy

Condition: Pharmacokinetics

NCT ID: NCT00616252

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Condition: IDV Associated Nephrotoxicity

NCT ID: NCT00477048

Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue

Condition: Bacterial Vaginosis; Vaginal Discharge

NCT ID: NCT01347632

Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women.

Condition: Healthy Volunteers

NCT ID: NCT00746499

A Study to Evaluate Safety and Immunogenicity of AERAS-402

Condition: Tuberculosis

NCT ID: NCT01378312

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Condition: Mycobacterium Tuberculosis

NCT ID: NCT01119521

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

Condition: Healthy Subjects

NCT ID: NCT00481182

GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

Condition: Healthy Volunteer

NCT ID: NCT00942136

Improving Effective Contraceptive Use Among Opioid-maintained Women

Condition: Contraceptive Usage; Opioid Dependence

NCT ID: NCT01425060

Effect of Genetics on Metabolism of Efavirenz

Condition: Metabolism

NCT ID: NCT00245986

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

Condition: Healthy Volunteers

NCT ID: NCT00925535

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Condition: Healthy Volunteers

NCT ID: NCT00474201

GSK706769 A First Time in Human Study For Males and Females

Condition: Healthy Subjects

NCT ID: NCT00539201

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

Condition: Cocaine Dependence; Cocaine-Related Disorders; Opioid-Related Disorders

NCT ID: NCT00780702

Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

Condition: Opiate-Related Disorders; Cocaine-Related Disorders

NCT ID: NCT00292110

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01290211

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01140412

GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects

Condition: Healthy

NCT ID: NCT01459315

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT01220232

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Condition: Chronic Hepatitis C; Chronic Hepatitis B

NCT ID: NCT00225537

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Condition: Healthy

NCT ID: NCT01308658

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT01230385

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Condition: Healthy

NCT ID: NCT01597895

Brief Intervention to Reduce STDs in ER Drug Users

Condition: Sexually Transmitted Infections.

NCT ID: NCT01379599

Comparison of the Shang Ring With Conventional Surgical Methods

Condition: Circumcision, Male

NCT ID: NCT01300910

Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment

Condition: Male Circumcision

NCT ID: NCT01247844

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)

Condition: Amphetamine-Related Disorders

NCT ID: NCT01449565

Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection

Condition: Hepatitis

NCT ID: NCT01102296

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Condition: Tuberculosis

NCT ID: NCT01424501

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Condition: Opiate Dependence

NCT ID: NCT00539123

TB Nutrition, Immunology and Epidemiology

Condition: Mycobacterium Tuberculosis

NCT ID: NCT00170404

The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT00936871

Long-Acting Reversible Contraception

Condition: Contraception

NCT ID: NCT01299116

Effectiveness of Sino-implant II

Condition: Sino-implant (II)

NCT ID: NCT01594632

Family Planning Through Dairy Cooperatives

Condition: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through; Land O' Lakes-supported Dairy Cooperatives

NCT ID: NCT01226433